Literature DB >> 9581788

Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo.

M Yanagi1, M St Claire, M Shapiro, S U Emerson, R H Purcell, J Bukh.   

Abstract

We constructed a chimeric cDNA clone of hepatitis C virus (HCV) that is infectious. The chimeric genome encodes the polyprotein of a genotype 1b strain (HC-J4) of HCV and replicates via 5' and 3' untranslated regions of a genotype 1a strain. The infectivity of three full-length cDNA clones was tested by direct injection of RNA transcripts into the liver of a chimpanzee. The chimpanzee became infected with HCV and the viral titer increased over time from 10(2) genome equivalents (GE)/ml at week 1 postinoculation (p.i.) to 10(4)-10(5) GE/ml during weeks 3-11 p.i. Antibodies to HCV were detected from week 18 p.i. However, the chimpanzee did not develop hepatitis. Sequence analysis of PCR products amplified from the serum of the chimpanzee demonstrated that only one of the three clones was infectious. Sequence comparisons with the cloning source, an acute-phase infectious plasma pool derived from an experimentally infected chimpanzee, showed that this infectious clone had three amino acids that differed from the consensus sequence of HC-J4, whereas the two noninfectious clones had seven and nine amino acid differences, respectively. Together, genotype 1b, represented by the infectious molecular clone described herein, and genotype 1a, represented by the two cDNA clones previously shown to be infectious for chimpanzees, account for the majority of HCV infections in the United States, Europe, and Japan.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581788     DOI: 10.1006/viro.1998.9092

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  80 in total

1.  Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus.

Authors:  B Beames; D Chavez; B Guerra; L Notvall; K M Brasky; R E Lanford
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.

Authors:  Harel Dahari; Stephen M Feinstone; Marian E Major
Journal:  Gastroenterology       Date:  2010-06-02       Impact factor: 22.682

3.  A milestone for hepatitis C virus research: a virus generated in cell culture is fully viable in vivo.

Authors:  Jens Bukh; Robert H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

4.  Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes.

Authors:  Stephen Griffin; Dean Clarke; Christopher McCormick; David Rowlands; Mark Harris
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Hepatitis C virus 3'X region interacts with human ribosomal proteins.

Authors:  J Wood; R M Frederickson; S Fields; A H Patel
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Broadening CD4+ and CD8+ T Cell Responses against Hepatitis C Virus by Vaccination with NS3 Overlapping Peptide Panels in Cross-Priming Liposomes.

Authors:  Jonathan Filskov; Marianne Mikkelsen; Paul R Hansen; Jan P Christensen; Allan R Thomsen; Peter Andersen; Jens Bukh; Else Marie Agger
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

7.  Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB.

Authors:  Y Sato; J Kato; R Takimoto; K Takada; Y Kawano; K Miyanishi; M Kobune; Y Sato; T Takayama; T Matunaga; Y Niitsu
Journal:  Gut       Date:  2006-03-31       Impact factor: 23.059

Review 8.  The hepatitis C virus persistence: how to evade the immune system?

Authors:  Nicole Pavio; Michael M C Lai
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

9.  Regulation of hepatitis C virus replication by interferon regulatory factor 1.

Authors:  Nobuhiko Kanazawa; Masayuki Kurosaki; Naoya Sakamoto; Nobuyuki Enomoto; Yasuhiro Itsui; Tsuyoshi Yamashiro; Yoko Tanabe; Shinya Maekawa; Mina Nakagawa; Cheng-Hsin Chen; Sei Kakinuma; Shigeru Oshima; Tetsuya Nakamura; Takanobu Kato; Takaji Wakita; Mamoru Watanabe
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Characterization of hepatitis C virus quasispecies by matrix-assisted laser desorption ionization-time of flight (mass spectrometry) mutation detection.

Authors:  Melissa Ayers; Karen Siu; Eve Roberts; Alex M Garvin; Raymond Tellier
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.